Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study

BACKGROUND: Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alteration...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Shinnyi, Fish, Kenneth N, Lewis, David A, Sweet, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120624/
https://www.ncbi.nlm.nih.gov/pubmed/37090672
http://dx.doi.org/10.1101/2023.04.11.536217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120624/
https://www.ncbi.nlm.nih.gov/pubmed/37090672
http://dx.doi.org/10.1101/2023.04.11.536217

Ejemplares similares